Search research articles
Contact Us
Filters
Showing results (101-110 of 142) with videos related to
Page
of 15
Sort By:
Nature Communications
|
April 27, 2018
Obesity exacerbates colitis-associated cancer via IL-6-regulated macrophage polarisation and CCL-20/CCR-6-mediated lymphocyte recruitment
Claudia M Wunderlich, P Justus Ackermann, Anna Lena Ostermann, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
October 15, 2014
Inhibition of protein geranylgeranylation specifically interferes with CD40-dependent B cell activation, resulting in a reduced capacity to induce T cell immunity
Alexander Shimabukuro-Vornhagen, Shahram Zoghi, Tanja M Liebig, et al.
Hemasphere
|
December 9, 2021
Obinutuzumab in Allogeneic Transplantation for CLL and Richter's Transformation in the Age of Targeted Therapies
Natali Pflug, Geothy Chakupurakal, Anna-Maria Fink, et al.
Cancer Immunology, Immunotherapy : CII
|
May 8, 2023
Correction to: CD33 BiTE<sup>®</sup> molecule-mediated immune synapse formation and subsequent T-cell activation is determined by the expression profile of activating and inhibitory checkpoint molecules on AML cells
Anetta Marcinek, Bettina Brauchle, Lisa Rohrbacher, et al.
Cancer Immunology, Immunotherapy : CII
|
April 11, 2023
CD33 BiTE<sup>®</sup> molecule-mediated immune synapse formation and subsequent T-cell activation is determined by the expression profile of activating and inhibitory checkpoint molecules on AML cells
Anetta Marcinek, Bettina Brauchle, Lisa Rohrbacher, et al.
Nature Medicine
|
July 8, 2024
A systematic review and meta-analysis of nonrelapse mortality after CAR T cell therapy
David M Cordas Dos Santos, Tobias Tix, Roni Shouval, et al.
Cancer Immunology Research
|
June 12, 2014
Microtubule-depolymerizing agents used in antibody-drug conjugates induce antitumor immunity by stimulation of dendritic cells
Philipp Müller, Kea Martin, Sebastian Theurich, et al.
Cancer Immunology, Immunotherapy : CII
|
April 17, 2024
Comparative performance of scFv-based anti-BCMA CAR formats for improved T cell therapy in multiple myeloma
Sophia Stock, Luisa Fertig, Adrian Gottschlich, et al.
Journal of Cancer Education : the Official Journal of the American Association for Cancer Education
|
April 1, 2026
A Mobile Exhibition to Advance Cancer Prevention Awareness: A Cross-Sectional Evaluation Using the RE-AIM Framework
Theres Fey, Theresa Herzig, Irina Rupp, et al.
Future Science OA
|
October 9, 2025
Personalized Combined Nutrition & Exercise Intervention in Newly Diagnosed Cancer Patients - a Trial Protocol
Sebastian Theurich, Timo Niels, Hansjoerg Baurecht, et al.
Page
of 15
Search research articles
Search
Showing results (101-110 of 142) with videos related to
Sort By:
Page
of 15
Nature Communications
|
April 27, 2018
Obesity exacerbates colitis-associated cancer via IL-6-regulated macrophage polarisation and CCL-20/CCR-6-mediated lymphocyte recruitment
Claudia M Wunderlich, P Justus Ackermann, Anna Lena Ostermann, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
October 15, 2014
Inhibition of protein geranylgeranylation specifically interferes with CD40-dependent B cell activation, resulting in a reduced capacity to induce T cell immunity
Alexander Shimabukuro-Vornhagen, Shahram Zoghi, Tanja M Liebig, et al.
Hemasphere
|
December 9, 2021
Obinutuzumab in Allogeneic Transplantation for CLL and Richter's Transformation in the Age of Targeted Therapies
Natali Pflug, Geothy Chakupurakal, Anna-Maria Fink, et al.
Cancer Immunology, Immunotherapy : CII
|
May 8, 2023
Correction to: CD33 BiTE<sup>®</sup> molecule-mediated immune synapse formation and subsequent T-cell activation is determined by the expression profile of activating and inhibitory checkpoint molecules on AML cells
Anetta Marcinek, Bettina Brauchle, Lisa Rohrbacher, et al.
Cancer Immunology, Immunotherapy : CII
|
April 11, 2023
CD33 BiTE<sup>®</sup> molecule-mediated immune synapse formation and subsequent T-cell activation is determined by the expression profile of activating and inhibitory checkpoint molecules on AML cells
Anetta Marcinek, Bettina Brauchle, Lisa Rohrbacher, et al.
Nature Medicine
|
July 8, 2024
A systematic review and meta-analysis of nonrelapse mortality after CAR T cell therapy
David M Cordas Dos Santos, Tobias Tix, Roni Shouval, et al.
Cancer Immunology Research
|
June 12, 2014
Microtubule-depolymerizing agents used in antibody-drug conjugates induce antitumor immunity by stimulation of dendritic cells
Philipp Müller, Kea Martin, Sebastian Theurich, et al.
Cancer Immunology, Immunotherapy : CII
|
April 17, 2024
Comparative performance of scFv-based anti-BCMA CAR formats for improved T cell therapy in multiple myeloma
Sophia Stock, Luisa Fertig, Adrian Gottschlich, et al.
Journal of Cancer Education : the Official Journal of the American Association for Cancer Education
|
April 1, 2026
A Mobile Exhibition to Advance Cancer Prevention Awareness: A Cross-Sectional Evaluation Using the RE-AIM Framework
Theres Fey, Theresa Herzig, Irina Rupp, et al.
Future Science OA
|
October 9, 2025
Personalized Combined Nutrition & Exercise Intervention in Newly Diagnosed Cancer Patients - a Trial Protocol
Sebastian Theurich, Timo Niels, Hansjoerg Baurecht, et al.
Page
of 15